STOCK TITAN

Insmed To Participate in Three November Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Insmed Incorporated (Nasdaq: INSM) announced its participation in three upcoming virtual investor conferences aimed at discussing the company's developments in biopharmaceuticals. On November 9, 2021, at 10:30 a.m. ET, Insmed will join the Credit Suisse 30th Annual Virtual Healthcare Conference. This will be followed by the Stifel 2021 Virtual Healthcare Conference on November 17, 2021, at 8:40 a.m. ET, and the Evercore ISI 4th Annual HealthCONx Virtual Conference on November 30, 2021, at 8:00 a.m. ET. All events will be webcast live and archived for 30 days.

Positive
  • None.
Negative
  • None.

BRIDGEWATER, N.J., Nov. 3, 2021 /PRNewswire/ -- Insmed Incorporated Inc. (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will participate in the following virtual investor conferences:

  • The Credit Suisse 30th Annual Virtual Healthcare Conference on November 9, 2021 at 10:30 a.m. ET in a fireside chat
  • The Stifel 2021 Virtual Healthcare Conference on November 17, 2021 at 8:40 a.m. ET in a fireside chat
  • The Evercore ISI 4th Annual HealthCONx Virtual Conference on November 30, 2021 at 8:00 a.m. ET in a fireside chat

Each fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Each webcast will be archived for a period of 30 days following the conclusion of each live event.

About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

(PRNewsfoto/Insmed Incorporated)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-participate-in-three-november-conferences-301414353.html

SOURCE Insmed Incorporated

FAQ

When will Insmed participate in the Credit Suisse Virtual Healthcare Conference?

Insmed will participate in the Credit Suisse 30th Annual Virtual Healthcare Conference on November 9, 2021, at 10:30 a.m. ET.

What date is the Stifel Virtual Healthcare Conference for Insmed?

Insmed will join the Stifel 2021 Virtual Healthcare Conference on November 17, 2021, at 8:40 a.m. ET.

When is Insmed's participation in the Evercore ISI HealthCONx Conference?

Insmed will participate in the Evercore ISI 4th Annual HealthCONx Virtual Conference on November 30, 2021, at 8:00 a.m. ET.

How can I access the webcasts of Insmed's conferences?

The webcasts of Insmed's conferences can be accessed through the investor relations section of their website and will be archived for 30 days post-event.

What is the mission of Insmed Incorporated?

Insmed is dedicated to transforming the lives of patients with serious and rare diseases.

Insmed, Inc.

NASDAQ:INSM

INSM Rankings

INSM Latest News

INSM Stock Data

12.06B
178.90M
0.91%
108.31%
7.66%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BRIDGEWATER